Antiretroviral therapy coverage for PMTCT in Morocco
Morocco: Antiretroviral therapy coverage for PMTCT was 72.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage for PMTCT in Morocco, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.
Analysis
In 2024, antiretroviral therapy coverage for pmtct in Morocco stood at 72.0%. That is the highest value across all 25 years on record.
The figure is up 26.3% on the previous year and up 100.0% over ten years.
Over the whole period, antiretroviral therapy coverage for pmtct in Morocco peaked at 72.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Morocco 49th out of 84 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage for PMTCT in Morocco, year by year
| Year | % of pregnant women living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 2.0% | — |
| 2006 | 5.0% | +150.0% |
| 2007 | 7.0% | +40.0% |
| 2008 | 10.0% | +42.9% |
| 2009 | 15.0% | +50.0% |
| 2010 | 20.0% | +33.3% |
| 2011 | 20.0% | +0.0% |
| 2012 | 32.0% | +60.0% |
| 2013 | 31.0% | -3.1% |
| 2014 | 36.0% | +16.1% |
| 2015 | 31.0% | -13.9% |
| 2016 | 40.0% | +29.0% |
| 2017 | 40.0% | +0.0% |
| 2018 | 42.0% | +5.0% |
| 2019 | 52.0% | +23.8% |
| 2020 | 48.0% | -7.7% |
| 2021 | 47.0% | -2.1% |
| 2022 | 55.0% | +17.0% |
| 2023 | 57.0% | +3.6% |
| 2024 | 72.0% | +26.3% |
Morocco compared with similar countries
- Morocco's 72.0% is below the median for lower middle income countries, which is 83.5%, 86% of the median. (32 countries reporting)
- Morocco's 72.0% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 32.0%, 2.2× the median. (9 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 3.9% | 0.0% | 15.0% | 10 |
| 2010s | 34.4% | 20.0% | 52.0% | 10 |
| 2020s | 55.8% | 47.0% | 72.0% | 5 |
Countries ranked near Morocco
More health data for Morocco
- Un projection of annual infant deaths, annual growth rate -1.91 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6655 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,240 deaths per 1,000 people (2090)
- Number of infants who die before age 1 925 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 3 (2018)
- Population ages 00-04, female, annual growth rate -1.13 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0396 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.1 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage for pmtct in Morocco?
- Antiretroviral therapy coverage for pmtct in Morocco was 72.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage for pmtct recorded in Morocco?
- The highest recorded value was 72.0% in 2024.
- What is the lowest antiretroviral therapy coverage for pmtct recorded in Morocco?
- The lowest recorded value was 0.0% in 2000.
- How does Morocco rank for antiretroviral therapy coverage for pmtct?
- Morocco ranks 49th out of 84 countries with data for 2024.
- Is antiretroviral therapy coverage for pmtct rising or falling in Morocco?
- Over the last ten years it is up 100.0%. The long-run trend across the full record is volatile.
- Where does this Morocco data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).